Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Times to Discontinue Antidepressants Over 6 Months in Patients with Major Depressive Disorder.

Jung WY, Jang SH, Kim SG, Jae YM, Kong BG, Kim HC, Choe BM, Kim JG, Kim CR.

Psychiatry Investig. 2016 Jul;13(4):440-6. doi: 10.4306/pi.2016.13.4.440. Epub 2016 Jul 25.

2.

The effect of knowledge and expectations on adherence to and persistence with antidepressants.

Woodward SC, Bereznicki BJ, Westbury JL, Bereznicki LR.

Patient Prefer Adherence. 2016 May 6;10:761-8. doi: 10.2147/PPA.S99803. eCollection 2016.

3.

Physician perception regarding side-effect profile at the onset of antidepressant treatment: a survey of Israeli psychiatrists and primary care physicians.

Nitzan U, Bekerman T, Becker G, Lichtenberg P, Lev-Ran S, Walter G, Maoz H, Bloch Y.

Ann Gen Psychiatry. 2016 Jan 29;15:5. doi: 10.1186/s12991-016-0090-6. eCollection 2016.

4.

Treatment discontinuation and tolerability as a function of dose and titration of duloxetine in the treatment of major depressive disorder.

Harada E, Shirakawa O, Satoi Y, Marangell LB, Escobar R.

Neuropsychiatr Dis Treat. 2016 Jan 11;12:89-97. doi: 10.2147/NDT.S86598. eCollection 2016.

5.

Monitoring patients on chronic treatment with antidepressants between 2003 and 2011: analysis of factors associated with compliance.

Serna MC, Real J, Cruz I, Galván L, Martin E.

BMC Public Health. 2015 Nov 26;15:1184. doi: 10.1186/s12889-015-2493-8.

6.

Evaluation of the Effectiveness of a Psychoeducational Intervention in Treatment-Naïve Patients with Antidepressant Medication in Primary Care: A Randomized Controlled Trial.

Casañas R, Catalán R, Penadés R, Real J, Valero S, Muñoz M, Lalucat-Jo L, Casas M.

ScientificWorldJournal. 2015;2015:718607. doi: 10.1155/2015/718607. Epub 2015 Aug 25.

7.

Treatment of Adults With Treatment-Resistant Depression: Electroconvulsive Therapy Plus Antidepressant or Electroconvulsive Therapy Alone? Evidence From an Indirect Comparison Meta-Analysis.

Song GM, Tian X, Shuai T, Yi LJ, Zeng Z, Liu S, Zhou JG, Wang Y.

Medicine (Baltimore). 2015 Jul;94(26):e1052. doi: 10.1097/MD.0000000000001052.

8.

Effect of clinician-patient communication on compliance with flupentixol-melitracen in functional dyspepsia patients.

Yan XJ, Li WT, Chen X, Wang EM, Liu Q, Qiu HY, Cao ZJ, Chen SL.

World J Gastroenterol. 2015 Apr 21;21(15):4652-9. doi: 10.3748/wjg.v21.i15.4652.

9.

A prospective observational study to evaluate safety reporting of antidepressants at a tertiary care hospital in India.

Lucca JM, Madhan R, Gurumurthy P, Dushad R.

Indian J Pharmacol. 2014 Sep-Oct;46(5):543-6. doi: 10.4103/0253-7613.140591.

10.

Noncontinuous use of antidepressant in adults with major depressive disorders - a retrospective cohort study.

Yau WY, Chan MC, Wing YK, Lam HB, Lin W, Lam SP, Lee CP.

Brain Behav. 2014 May;4(3):390-7. doi: 10.1002/brb3.224. Epub 2014 Mar 14.

11.

Associations between antidepressant adherence and shared decision-making, patient-provider trust, and communication among adults with diabetes: diabetes study of Northern California (DISTANCE).

Bauer AM, Parker MM, Schillinger D, Katon W, Adler N, Adams AS, Moffet HH, Karter AJ.

J Gen Intern Med. 2014 Aug;29(8):1139-47. doi: 10.1007/s11606-014-2845-6.

12.

Antidepressant utilization after hospitalization with depression: a comparison between non-Western immigrants and Danish-born residents.

Wallach-Kildemoes H, Thomsen LT, Kriegbaum M, Petersen JH, Norredam M.

BMC Psychiatry. 2014 Mar 17;14:77. doi: 10.1186/1471-244X-14-77.

13.

Predictors of primary care management of depression in the Veterans Affairs healthcare system.

Chang ET, Magnabosco JL, Chaney E, Lanto A, Simon B, Yano EM, Rubenstein LV.

J Gen Intern Med. 2014 Jul;29(7):1017-25. doi: 10.1007/s11606-014-2807-z. Epub 2014 Feb 25.

14.

Preventing depressive relapse and recurrence in higher-risk cognitive therapy responders: a randomized trial of continuation phase cognitive therapy, fluoxetine, or matched pill placebo.

Jarrett RB, Minhajuddin A, Gershenfeld H, Friedman ES, Thase ME.

JAMA Psychiatry. 2013 Nov;70(11):1152-60. doi: 10.1001/jamapsychiatry.2013.1969.

15.

Adherence to antidepressant medications: an evaluation of community pharmacists' counseling practices.

Chong WW, Aslani P, Chen TF.

Patient Prefer Adherence. 2013 Aug 21;7:813-25. doi: 10.2147/PPA.S48486. eCollection 2013. Erratum in: Patient Prefer Adherence. 2013;7:1059.

16.

The relationship between self-reported and registry-based data on use of psychoactive medications in postmenopausal women.

Rauma PH, Koivumaa-Honkanen H, Kröger H, Tuppurainen MT, Kauhanen J, Honkanen RJ.

BMC Psychiatry. 2013 Jul 2;13:180. doi: 10.1186/1471-244X-13-180.

17.

Follow up of patients who start treatment with antidepressants: treatment satisfaction, treatment compliance, efficacy and safety.

López-Torres J, Párraga I, Del Campo JM, Villena A; ADSCAMFYC Group.

BMC Psychiatry. 2013 Feb 20;13:65. doi: 10.1186/1471-244X-13-65.

18.

Assessment of physician practices in adult attention-deficit/hyperactivity disorder.

Goodman DW, Surman CB, Scherer PB, Salinas GD, Brown JJ.

Prim Care Companion CNS Disord. 2012;14(4). pii: PCC.11m01312. doi: 10.4088/PCC.11m01312. Epub 2012 Aug 2.

19.

Is treatment adherence consistent across time, across different treatments and across diagnoses?

Simon GE, Peterson D, Hubbard R.

Gen Hosp Psychiatry. 2013 Mar-Apr;35(2):195-201. doi: 10.1016/j.genhosppsych.2012.10.001. Epub 2012 Nov 9.

20.

The effect of clinician-patient alliance and communication on treatment adherence in mental health care: a systematic review.

Thompson L, McCabe R.

BMC Psychiatry. 2012 Jul 24;12:87. doi: 10.1186/1471-244X-12-87. Review.

Items per page

Supplemental Content

Write to the Help Desk